Weekly Roundup: Scoring big in biopharma

The World Cup kicked off this week and so did our clients, with new appointments, important clinical trial updates and major collaborations announced! The Optimum team was proud to support and attend Weatherden’s Symposium on Women’s Health yesterday, which featured a stellar line-up of speakers to explore how smarter clinical development and regulatory strategy can […]

Weekly Roundup: Biotech in bloom this June

The heatwave has been replaced by heavy showers, but June is looking bright for our clients, with huge congratulations to Ona Therapeutics for its $86.6M Series B financing and to DaltonTx  for the launch of its AI-enabled drug discovery platform. Dr. Hans Eriksson is joining FundaMental Pharma’s team as CMO and Renée Aguiar-Lucander participated in […]

Hot Topic: Who do you trust – man or machine?

Last month I went to Copenhagen for the LSX Nordic conference, which was great. The metro ride from the airport to the city centre in a driverless train was a novelty for me, as tube trains on the London Underground all have drivers. I thought no more about it. What if, though, the aeroplane in […]

Weekly Roundup: Commercial expansion, collaborations & clinical progress

Despite the short Bank Holiday week, it’s as busy as ever. Collaborative expansion is in full swing as Bonito Biosciences and DaltonTx join forces, and ViCentra triples Kaleido consumables production capacity through Phillips Medisize partnership. Hansa Biopharma, Poolbeg Pharma and Synklino have been enjoying progress this week, as Hansa reports positive efficacy and safety results […]

© Optimum Strategic Communications.